Asthma and Respiratory Center of South Dayton INC

Asthma and Respiratory Center of South Dayton INC was paid $182K by Medicaid between Jan 2018 and Dec 2024, across 9 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 84% of everything it billed.

33Billing provider infoASTHMA AND RESPIRATORY CENTER OF SOUTH DAYTON INC
CENTERVILLE, OH 45458

33aNPI1508040908assigned 12/20/2007

33bProvider typePulmonary Disease Physician

28Total paid$182K

24GClaims4,723

24DCodes billed9

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Pulmonary Disease Physician providers in Ohio

Rank by total paid#11 of 42

Median peer was paid$34K

This provider vs. median5.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	909	$36K
2019	1,080	$38K
2020	199	$8K
2021	468	$17K
2022	602	$25K
2023	660	$26K
2024incomplete	805	$32K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	84%	3,142	2,669	$152K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	8.0%	529	412	$15K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	3.4%	341	294	$6K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	2.2%	61	57	$4K
94729		1.4%	153	142	$3K
94726		1.3%	137	127	$2K
99406		<1%	13	13	$92.39
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	79	68	$43.25
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	268	232	$28.87

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWAGSHUL, FRED (OWNER/ CEO)